ISSN 1674-3865  CN 21-1569/R
主管:国家卫生和计划生育委员会
主办:中国医师协会
   辽宁省基础医学研究所
   辽宁中医药大学附属医院

Chinese Pediatrics of Integrated Traditional and Western Medicine ›› 2017, Vol. 9 ›› Issue (1): 49-52.doi: 10.3969/j.issn.1674-3865.2017.01.015

Previous Articles     Next Articles

Clinical effects of Fuganlin oral solution on bronchiolitis with phlegm-heat closing lungs

LI Ran,SUN Yanhong   

  1. Department of Pediatrics,Laiwu People's Hospital,Laiwu Hospital Affiliated to Taishan Medical College,Laiwu 271100,China
  • Published:2017-02-25 Online:2017-12-18

Abstract:
Objective: To observe the clinical effects of Fuganlin oral solution on bronchiolitis with phlegm-heat closing lungs.
Methods: Between April 2015 and March 2016,106 cases were diagnosed as bronchiolitis with phlegm-heat closing lungs in our hospital; they were randomly divided into 2 groups. The control group(52 cases) was treated with intravenous ribavirin and budesonide and ventolin inhalation. The treatment group(54 cases) was given Fuganlin oral solution besides routine therapy. The treatment lasted for 7 days. The treatment results were compared.
Results: On the 3rd day, the symptoms of cough, sputum, and fever in observation group were improved markedly compared with the control group(P<0.05); on the 5th day, the effective rates of all symptoms were higher than the control group except for fever(P<0.05).
Conclusion: The Fuganlin oral solution combined with routine therapy is an effective and safe treatment for the children with bronchiolitis with phlegm-heat closing lungs.

Key words: Bronchiolitis, Phlegm-heat closing lungs, Fuganlin oral solution, Children